Brookstone Capital Management Exact Sciences Corp Transaction History
Brookstone Capital Management
- $6.01 Billion
- Q3 2024
A detailed history of Brookstone Capital Management transactions in Exact Sciences Corp stock. As of the latest transaction made, Brookstone Capital Management holds 14,953 shares of EXAS stock, worth $791,163. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,953
Previous 12,806
16.77%
Holding current value
$791,163
Previous $541,000
88.17%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding EXAS
# of Institutions
670Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$940 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$838 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$758 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$638 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$353 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.36B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...